JPRN-UMIN000038561招募中未知
The study of therapeutic drug development with neurodegenerative diseases by using iPS cells derived from patients' samples. - The study of therapeutic drug development with neurodegenerative diseases by using iPS cells derived from patients' samples.
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •<Amyotrophic lateral sclerosis (ALS)> Exclude the following diseases. Other motor neuron disorders, motor neurophathy, cervical spondylosis, and inflammatory myopathy such as inclusion body myositis. <Idiopathic basal ganglia calcification (IBGC)> To exclude diseases which show calcification, because of some causes such as hypoparathyroism, pseudo hypoparathyroism, pseudopseudo hypoparathyroism (Albright's osteodystrophy), Down syndrome, collagen diseases, angiitis, infections, intoxication, trauma, radiation therapy and so on.
研究者
相似试验
尚未招募
不适用
Drug monitoring method for Dasatinib in blood cancer patientsCTRI/2020/09/027561Tata Memorial Centre
进行中（未招募）
1 期
Prospective study to assess the emergence of drug resistance to oseltamivir following treatment of acute influenza A among children - Oseltamivir resistance studyInfluenza AEUCTR2005-005239-80-GBniversity Hospitals Leicester, Leicester General Hospital100
进行中（未招募）
不适用
Dexmedetomidine PKPD and effect of stimulatioEUCTR2012-005443-24-NLMCG
已完成
不适用
Development of a pharmacokinetic/pharmacodynamic model of dexmedetomidine, and the effect of repeated auditory stimulation on pharmacodynamics of dexmedetomidine.*gezonde vrijwilligers, dus geen aandoeningenpharmacodynamicPharmacokineticNL-OMON39625niversitair Medisch Centrum Groningen18
已完成
1 期
Design and preliminary characterisation of a drug delivery system based on polyurethane particlesR20.8R21Other and unspecified disturbances of skin sensationRash and other nonspecific skin eruptionDRKS00023265Victor Babes University of Medicine and Pharmacy6